Enzymatica publ AB (ENZY) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.085x

Based on the latest financial reports, Enzymatica publ AB (ENZY) has a cash flow conversion efficiency ratio of -0.085x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-11.57 Million ≈ $-1.24 Million USD) by net assets (Skr135.68 Million ≈ $14.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Enzymatica publ AB balance sheet quality to measure how much of total assets are equity-financed.

Enzymatica publ AB - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Enzymatica publ AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Enzymatica publ AB cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Enzymatica publ AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Enzymatica publ AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Surf Air Mobility Inc. NYSE:SRFM	0.209x
360 Capital Group AU:TGP	0.011x
W S Industries (I) Limited NSE:WSI	0.030x
Shield On Service Tbk PT JK:SOSS	0.097x
Diatreme Resources Ltd AU:DRX	-0.020x
180 Degree Capital Corp NASDAQ:TURN	-0.083x
Joosung Corperation KO:109070	0.150x
YOUNGHWA TECH Co. Ltd KQ:265560	0.063x

Annual Cash Flow Conversion Efficiency for Enzymatica publ AB (2009–2024)

The table below shows the annual cash flow conversion efficiency of Enzymatica publ AB from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see ENZY company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr176.37 Million ≈ $18.98 Million	Skr-60.51 Million ≈ $-6.51 Million	-0.343x	+34.76%
2023-12-31	Skr76.61 Million ≈ $8.24 Million	Skr-40.29 Million ≈ $-4.34 Million	-0.526x	-2.86%
2022-12-31	Skr126.29 Million ≈ $13.59 Million	Skr-64.57 Million ≈ $-6.95 Million	-0.511x	-78.12%
2021-12-31	Skr124.97 Million ≈ $13.45 Million	Skr-35.87 Million ≈ $-3.86 Million	-0.287x	-187.36%
2020-12-31	Skr106.65 Million ≈ $11.48 Million	Skr-10.65 Million ≈ $-1.15 Million	-0.100x	+68.32%
2019-12-31	Skr119.20 Million ≈ $12.83 Million	Skr-37.58 Million ≈ $-4.04 Million	-0.315x	-74.80%
2018-12-31	Skr159.66 Million ≈ $17.18 Million	Skr-28.79 Million ≈ $-3.10 Million	-0.180x	+11.46%
2017-12-31	Skr110.70 Million ≈ $11.91 Million	Skr-22.55 Million ≈ $-2.43 Million	-0.204x	+24.73%
2016-12-31	Skr142.04 Million ≈ $15.29 Million	Skr-38.43 Million ≈ $-4.14 Million	-0.271x	+84.20%
2015-12-31	Skr21.98 Million ≈ $2.37 Million	Skr-37.65 Million ≈ $-4.05 Million	-1.712x	-162.87%
2014-12-31	Skr62.42 Million ≈ $6.72 Million	Skr-40.67 Million ≈ $-4.38 Million	-0.651x	+44.40%
2013-12-31	Skr15.73 Million ≈ $1.69 Million	Skr-18.43 Million ≈ $-1.98 Million	-1.172x	-127.13%
2012-12-31	Skr14.06 Million ≈ $1.51 Million	Skr-7.25 Million ≈ $-780.54K	-0.516x	+64.79%
2011-12-31	Skr3.31 Million ≈ $356.64K	Skr-4.86 Million ≈ $-522.58K	-1.465x	-1395.19%
2009-12-31	Skr-901.48K ≈ $-97.01K	Skr-101.99K ≈ $-10.98K	0.113x	--

About Enzymatica publ AB

ST:ENZY Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$49.63 Million

Skr461.20 Million SEK

Market Cap Rank

#21871 Global

#408 in Sweden

Share Price

Skr1.90

Change (1 day)

+2.43%

52-Week Range

Skr1.65 - Skr3.20

All Time High

Skr770.83